Supplementary Methods, Figures 1-3, Table 1 from Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/Autotaxin Inhibitor Reduces Breast Cancer Cell Migration &lt;i&gt;In vitro&lt;/i&gt; and Causes Tumor Regression &lt;i&gt;In vivo&lt;/i&gt;